Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urethral Neoplasms × Gefitinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 26 Lung Neoplasms 9 Head and Neck Neoplasms 5 Adenocarcinoma of Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Skin Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Gliosarcoma 2 Glioblastoma 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma 2 Breast Neoplasms 2 Brain Neoplasms 2 Adenocarcinoma Of Esophagus 2 Urinary Bladder Neoplasms 1 Untreated Childhood Anaplastic Astrocytoma 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Salivary Gland Neoplasms 1 Recurrence 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Squamous Cell 1 Lymphoid Interstitial Pneumonia 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Laryngeal Diseases 1

Interventions

Gemcitabine 7 Cisplatin 5 Ramucirumab 3 Platinum 3 Paclitaxel 3 Docetaxel 3 1,2-diaminocyclohexaneplatinum II citrate 3 pembrolizumab 2 Carboplatin 2 rucaparib 1 pegfilgrastim 1 pazopanib 1 eribulin 1 enzalutamide 1 enfortumab vedotin 1 dehydroftorafur 1 avelumab 1 atezolizumab 1 aflibercept 1 Taxes 1 Surgical Procedures, Operative 1 Sunitinib 1 Standard of Care 1 Specimen Handling 1 Sorafenib 1 Radiotherapy 1 Radiation 1 N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide 1 Mitozytrex 1 Mitomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡